James Atherton
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Antibiotics Pharmacokinetics and Efficacy
-
- Antibiotic Resistance in Bacteria
Papers in
-
- Metabolomics and Mass Spectrometry Studies 2
-
- Pharmacogenetics and Drug Metabolism 2
- Drug-Induced Hepatotoxicity and Protection 2
- Co-authors
- Abdul Mutlib (5 shared papers)Jonathan Steele (1 shared paper)Stephen K. Wrigley (1 shared paper)Jason Boer (1 shared paper)Amit S. Kalgutkar (2 shared papers)Shaila Kulkarni (1 shared paper)Stephen C. Strom (1 shared paper)Bo Feng (1 shared paper)
- Journals
- Chemical Research in Toxicology (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Drug Metabolism and Disposition (1 paper)Toxicological Sciences (1 paper)Endocrinology (1 paper)
- Partner nations
- United StatesPolandUnited Kingdom
In The Last Decade
James Atherton
10 papers receiving 389 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 124
- Molecular Medicine 33
- Physiology 28
- Pharmacology 55
- Oncology 76
Countries citing papers authored by James Atherton
This map shows the geographic impact of James Atherton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Atherton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Atherton more than expected).
Fields of papers citing papers by James Atherton
This network shows the impact of papers produced by James Atherton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Atherton. The network helps show where James Atherton may publish in the future.
Co-authors
The 25 scholars most cited alongside James Atherton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 91 | |
| 2 | 2020 | 76 | |
| 3 | 2007 | 44 | |
| 4 | 2014 | 43 | |
| 5 | 2008 | 39 | |
| 6 | 2007 | 38 | |
| 7 | 2008 | 32 | |
| 8 | 2012 | 22 | |
| 9 | 2010 | 14 | |
| 10 | 2007 | 5 |
About James Atherton
James Atherton is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Cardiology and Cardiovascular Medicine and Oncology, having authored 10 papers that have together received 404 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Estrogen and related hormone effects (1 paper), Hypothalamic control of reproductive hormones (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Synthesis of β-Lactam Compounds (1 paper). The work is most often cited by research in Pharmacology (124 citations), Molecular Medicine (33 citations), Physiology (28 citations), Pharmacology (55 citations) and Oncology (76 citations). James Atherton has collaborated with scholars based in United States, Poland and United Kingdom. Frequent co-authors include Abdul Mutlib, Jonathan Steele, Stephen K. Wrigley, Jason Boer, Amit S. Kalgutkar, Shaila Kulkarni, Stephen C. Strom, Bo Feng, Gregory S. Walker and Anshul Gupta. Their work appears in journals such as Chemical Research in Toxicology, Bioorganic & Medicinal Chemistry Letters, Drug Metabolism and Disposition, Toxicological Sciences and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.